PROSTVAC Trademark

Trademark Overview

On Wednesday, September 24, 2008, a trademark application was filed for PROSTVAC with the United States Patent and Trademark Office. The USPTO has given the PROSTVAC trademark a serial number of 77577729. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 11, 2021. This trademark is owned by BN ImmunoTherapeutics Inc.. The PROSTVAC trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines and recombinant vectors of pox used to prepare vaccines and biological immunogens for use in humans *; all these goods for use in the field of prostate cancer *
prostvac

General Information

Serial Number77577729
Word MarkPROSTVAC
Filing DateWednesday, September 24, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 11, 2021
Registration Number3873966
Registration DateTuesday, November 9, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2010

Trademark Statements

Amendment to a Registration/Renewal CertificateIn the statement, Column 1, line 5 after humans, all these goods for use in the field of prostate cancer is inserted.
Goods and ServicesVaccines and recombinant vectors of pox used to prepare vaccines and biological immunogens for use in humans *; all these goods for use in the field of prostate cancer *

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 11, 2021
Primary Code005
First Use Anywhere DateMonday, March 23, 2009
First Use In Commerce DateSunday, March 29, 2009

Trademark Owner History

Party NameBN ImmunoTherapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameBN ImmunoTherapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameBN ImmunoTherapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events

Event DateEvent Description
Friday, June 11, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, November 9, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, January 19, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, January 19, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 19, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 9, 2016TEAS SECTION 8 & 15 RECEIVED
Monday, November 9, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 11, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 1, 2012AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Wednesday, February 1, 2012SEC 7 REQUEST FILED
Tuesday, December 20, 2011TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, September 6, 2011POST REGISTRATION ACTION MAILED - SEC. 7
Monday, September 5, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 9, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, January 6, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 9, 2010REGISTERED-PRINCIPAL REGISTER
Friday, October 8, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 7, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, October 6, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 28, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 26, 2010STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 1, 2010USE AMENDMENT FILED
Sunday, September 26, 2010EXTENSION 1 GRANTED
Wednesday, September 1, 2010EXTENSION 1 FILED
Sunday, September 26, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 1, 2010TEAS EXTENSION RECEIVED
Wednesday, September 1, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, May 18, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 24, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 23, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2010PUBLISHED FOR OPPOSITION
Thursday, January 21, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 21, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 14, 2010SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, January 14, 2010ASSIGNED TO LIE
Tuesday, July 14, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, July 14, 2009LETTER OF SUSPENSION E-MAILED
Tuesday, July 14, 2009SUSPENSION LETTER WRITTEN
Saturday, June 27, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 26, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 26, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 14, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 26, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 26, 2008NON-FINAL ACTION E-MAILED
Friday, December 26, 2008NON-FINAL ACTION WRITTEN
Monday, December 22, 2008ASSIGNED TO EXAMINER
Monday, September 29, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

prostvac vaccines these goods field cancer prostate humans immunogens recombinant vectors